Keystone Symposia “Emerging Cellular Therapies”
January 22, 2024 ‐ January 25, 2024 in Santa Fe, New Mexico, USA
The Keystone Symposia “Emerging Cellular Therapies” will take place January 22-25, 2024 in Santa Fe Community Convention Center, New Mexico, United States.
Cellectis will be presenting in two poster sessions as follows:
Poster P1021
Title: Preclinical efficacy of PD-L1/TGF-beta resistant MUC1-CAR T-cells with inducible IL12 against triple-negative breast cancer
Session: Poster Session 1
Presenter: Piril Erler, Scientist II, Immuno-Oncology
Date/Time: Tuesday, January 23rd, 2024 at 12:00 PM MST
Poster (P1016)
Title: TALEN®-edited Allogeneic Inducible Dual CAR T-cells Enable Effective Targeting of Solid Tumors while Mitigating Off-Tumor Toxicity
Session: Poster Session 1
Presenter: Shipra Das, Associate Director, Immuno-Oncology
Date/Time: Tuesday, January 23rd, 2024 at 12:00 PM MST
Link to register to the conference: https://www.keystonesymposia.org/conferences/conference-listing/meeting?eventid=6993